Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Alexandrakis

Showing results (91-100 of 141) with videos related to

Pageof 15
Sort By:
Nephron|September 30, 2015
Activated Protein C-Resistance Determination and Vascular Access Thrombosis in Populations with High Prevalence of Factor V LeidenNikolaos E Androulakis, Nikolaos Tzenakis, Eleni Nioti, et al.
Anticancer Research|January 29, 2000
Carcinoma of the ampulla of Vater in Crete. A clinical and ERCP registry over eight yearsI A Mouzas, P Skordilis, N Frangiadakis, et al.
Biomed Research International|August 13, 2013
Relationship between circulating BAFF serum levels with proliferating markers in patients with multiple myelomaMichael G Alexandrakis, Parascevi Roussou, Constantina A Pappa, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|June 23, 2005
Celiac artery aneurysm associated with atherosclerotic common hepatic artery stenosisD K Papadimitriou, G A Pitoulias, M D Tachtsi, et al.
Hepato-Gastroenterology|April 9, 2005
Capsule endoscopy; the cumulative experience from its use in 193 patients with suspected small bowel diseaseN Kalantzis, I S Papanikolaou, E Giannakoulopoulou, et al.
International Journal of Hematology|August 16, 2001
Reduced CD43 expression on the neutrophils of MDS patients correlates with an activated phenotype of these cellsDespina Kyriakou, Michael G Alexandrakis, Elias S Kyriakou, et al.
Annals of Hematology|April 25, 2012
B cell-activating factor: its clinical significance in multiple myeloma patientsM Fragioudaki, A Boula, G Tsirakis, et al.
Clinical and Laboratory Haematology|December 15, 2004
Levels of soluble forms of ICAM and VCAM in patients with myelodysplastic syndromes and their prognostic significanceF H Passam, G Tsirakis, A Boula, et al.
Medical Oncology (Northwood, London, England)|December 26, 2012
Lack of correlation between angiogenic cytokines and serum insulin-like growth factor-1 in patients with multiple myelomaC A Pappa, G Tsirakis, F E Psarakis, et al.
Hematological Oncology|April 12, 2013
Emerging roles of endoglin/CD105 and angiogenic cytokines for disease development and progression in multiple myeloma patientsC A Pappa, M G Alexandrakis, A Boula, et al.
Pageof 15

Showing results (91-100 of 141) with videos related to

Sort By:
Pageof 15
Nephron|September 30, 2015
Activated Protein C-Resistance Determination and Vascular Access Thrombosis in Populations with High Prevalence of Factor V LeidenNikolaos E Androulakis, Nikolaos Tzenakis, Eleni Nioti, et al.
Anticancer Research|January 29, 2000
Carcinoma of the ampulla of Vater in Crete. A clinical and ERCP registry over eight yearsI A Mouzas, P Skordilis, N Frangiadakis, et al.
Biomed Research International|August 13, 2013
Relationship between circulating BAFF serum levels with proliferating markers in patients with multiple myelomaMichael G Alexandrakis, Parascevi Roussou, Constantina A Pappa, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|June 23, 2005
Celiac artery aneurysm associated with atherosclerotic common hepatic artery stenosisD K Papadimitriou, G A Pitoulias, M D Tachtsi, et al.
Hepato-Gastroenterology|April 9, 2005
Capsule endoscopy; the cumulative experience from its use in 193 patients with suspected small bowel diseaseN Kalantzis, I S Papanikolaou, E Giannakoulopoulou, et al.
International Journal of Hematology|August 16, 2001
Reduced CD43 expression on the neutrophils of MDS patients correlates with an activated phenotype of these cellsDespina Kyriakou, Michael G Alexandrakis, Elias S Kyriakou, et al.
Annals of Hematology|April 25, 2012
B cell-activating factor: its clinical significance in multiple myeloma patientsM Fragioudaki, A Boula, G Tsirakis, et al.
Clinical and Laboratory Haematology|December 15, 2004
Levels of soluble forms of ICAM and VCAM in patients with myelodysplastic syndromes and their prognostic significanceF H Passam, G Tsirakis, A Boula, et al.
Medical Oncology (Northwood, London, England)|December 26, 2012
Lack of correlation between angiogenic cytokines and serum insulin-like growth factor-1 in patients with multiple myelomaC A Pappa, G Tsirakis, F E Psarakis, et al.
Hematological Oncology|April 12, 2013
Emerging roles of endoglin/CD105 and angiogenic cytokines for disease development and progression in multiple myeloma patientsC A Pappa, M G Alexandrakis, A Boula, et al.
Pageof 15